Literature DB >> 6621559

The syndrome scales in the AMDP-System.

A Pietzcker, R Gebhardt, A Strauss, M Stöckel, C Langer, K Freudenthal.   

Abstract

Mesh:

Year:  1983        PMID: 6621559     DOI: 10.1159/000407832

Source DB:  PubMed          Journal:  Mod Probl Pharmacopsychiatry        ISSN: 0077-0094


× No keyword cloud information.
  5 in total

1.  The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.

Authors:  Hans-Jürgen Möller; Markus Jäger; Michael Riedel; Michael Obermeier; Anton Strauss; Ronald Bottlender
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-22       Impact factor: 5.270

2.  Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of Germany.

Authors:  B Bandelow; P Müller; U Frick; W Gaebel; M Linden; F Müller-Spahn; A Pietzcker; J Tegeler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

3.  Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.

Authors:  B Bandelow; P Müller; W Gaebel; W Köpcke; M Linden; F Müller-Spahn; A Pietzcker; F M Reischies; J Tegeler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

Review 4.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

5.  Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome.

Authors:  Alexandra Kleimann; Sermin Toto; Christian K Eberlein; Jan T Kielstein; Stefan Bleich; Helge Frieling; Marcel Sieberer
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.